Later, Conry et al. proved the feasibility of using an mRNA encoding tumoral antigens as a cancer vaccine by the immunization of mice with an mRNA encoding the human carcinoembryonic antigen (CEA), which were later challenged with CEA-expressing tumor cells. Here, CEACAM5 is linked to neoplasm.